Robert Debernardo News Today

Robert DeBernardo, MD, discusses a case study seen in a patient with ovarian cancer.

Robert DeBernardo, MD, discusses the use of maintenance therapy in the second- and later-line settings for patients with ovarian cancer.

Robert DeBernardo, MD, discusses the current role of PARP inhibitors in the frontline treatment landscape in ovarian cancer.

Each year nearly 12,000 American women develop cervical cancer and 4,000 die, but experts say a change in guidelines may be causing those cases to rise.

Some doctors say it could be the change in how many times women should get a PAP.

Research shows that late-stage cervical cancer is on the rise. Doctors at Cleveland Clinic say that could be due in part to the pandemic and the change in guidelines for pap smears.

January is Cervical Cancer Awareness Month, and research shows that late-stage cervical cancer appears to be on the rise.

According to a study released last year, late-stage cervical cancer appears to be on the rise.

According to a study released last year, late-stage cervical cancer appears to be on the rise.

While there has been a decline in cases among young women, those 65 and older represent about 20% of new cases.